Study on ALKAL1: A Potential Drug Target for Neurodegenerative Diseases

Target Name: ALKAL1

NCBI ID: G389658

ALKAL1

Study on ALKAL1: A Potential Drug Target for Neurodegenerative Diseases

ALKAL1 (AUGA) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, liver, and kidneys. It is a member of the Tissue Response Proteins (TRPs) family, which are a group of proteins that are involved in various cellular processes in the body, including inflammation, stress, and repair.

One of the unique features of ALKAL1 is its ability to interact with other proteins that are expressed in the brain, including the neurotransmitter glutamate. Glutamic acid is an important neurotransmitter that can stimulate nerve cells and thereby transmit nerve signals. Under normal circumstances, glutamate is quickly broken down into glutamate, but under stress and disease conditions, glutamate may accumulate in nerve cells, causing nerve cell damage.

Therefore, it is very important to study the role of ALKAL1 in nerve cells. Scientists have discovered that ALKAL1 inhibits the effects of glutamate, thereby protecting nerve cells from damage. This provides new ideas for studying ALKAL1 as a therapeutic target for neurodegenerative diseases.

In addition, ALKAL1 interacts with many other proteins, including ligands of receptors on the cell membrane. These interactions allow ALKAL1 to participate in a variety of different biological processes, such as cell proliferation, apoptosis, cell signaling, and cell metabolism.

ALKAL1 is also closely related to the occurrence and development of some diseases. For example, ALKAL1 plays an important role in the pathogenesis of diseases such as Alzheimer's disease, Parkinson's disease, and liver disease. In these diseases, the role of glutamate and the function of ALKAL1 may be closely related to the occurrence and development of the disease.

Therefore, the potential role of ALKAL1 as a drug target or biomarker in neuroscience and disease treatment has received extensive research and attention. Future research will continue to deeply explore the function and mechanism of ALKAL1, providing new ideas and methods for neuroscience and disease treatment.

Protein Name: ALK And LTK Ligand 1

Functions: Cytokine that acts as a physiological ligand for receptor tyrosine kinase LTK, leading to its activation (PubMed:25331893, PubMed:26418745, PubMed:26630010, PubMed:34646012, PubMed:34819673). Monomeric ALKAL1 binds to LTK, leading to LTK homodimerization and activation (PubMed:34646012, PubMed:34819673). In contrast to ALKAL2, does not act as a potent physiological ligand for ALK (PubMed:26418745, PubMed:34646012)

The "ALKAL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALKAL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets